Repurposing and repositioning have gained considerable attention from a range of stakeholders, including NIH, academic institutions, pharmaceutical companies, and even some technology companies, for ...

Before a drug can be used to treat a disease, it must go through a lengthy and expensive trial process to prove both safety and effectiveness. By repurposing already-approved drugs, researchers can ...

Technological advances and the increasing availability of genomic data and computational systems have resulted in new methods to systematically identify both drug targets and pathways for detecting ...

Using examples of drugs and companies, Dr Andreas Persidis gives tips on how to establish a systematic drug repositioning programme IP is the asset of the pharmaceutical industry. The current ...

Intracellular bacterial pathogens pose a major challenge to current antimicrobial therapies due to their ability to survive and replicate within host cells, ...